Arteriolar remodeling in essential hypertension: are connective tissue growth factor and transforming growth factor involved? (Q83144602)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16609677%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

Arteriolar remodeling in essential hypertension: are connective tissue growth factor and transforming growth factor involved? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16609677%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

essential hypertension

1 reference

B Rodriguez-Iturbe

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16609677%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

language of work or name

English

0 references

publication date

1 April 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16609677%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16609677%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

69

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16609677%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16609677%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

1104-1105

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16609677%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.ki.5000222

19 January 2020

exact match

0 references

cites work

Structure and mechanical properties of resistance arteries in hypertension: role of adhesion molecules and extracellular matrix determinants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000222

7 January 2021

Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000222

7 January 2021

Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000222

7 January 2021

Losartan improves resistance artery lesions and prevents CTGF and TGF-beta production in mild hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000222

7 January 2021

Molecular mechanisms of angiotensin II-induced vascular injury.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000222

7 January 2021

Connective tissue growth factor is a mediator of angiotensin II-induced fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000222

7 January 2021

Novel mechanisms of the antiproliferative effects of amlodipine in vascular smooth muscle cells from spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000222

7 January 2021

Ca2+ channel blockers modulate metabolism of collagens within the extracellular matrix

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000222

7 January 2021

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000222

7 January 2021